COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CMPS COMPASS Pathways plc

Not Yet Opened 11-11 16:00:00 EST

9.30

+0.05

+0.54%

盘后9.27

-0.03-0.31%

19:58 EST

High9.50	Low9.03	Vol2.62M
Open9.50	D1 Closing9.25	Amplitude5.08%
Mkt Cap1.32B	Tradable Cap1.02B	Total Shares141.71M
T/O24.34M	T/O Rate2.39%	Tradable Shares110.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CMPS","market":"US","secType":"STK","nameCN":"COMPASS Pathways plc","latestPrice":9.3,"timestamp":1794430800000,"preClose":9.25,"halted":0,"volume":2624242,"hourTrading":{"tag":"盘后","latestPrice":9.2713,"preClose":9.3,"latestTime":"19:58 EST","volume":23449,"amount":218139.8912,"timestamp":1794445129671,"change":-0.0287,"changeRate":-0.003086,"amplitude":0.02043},"delay":0,"changeRate":0.005405405405405482,"floatShares":110000000,"shares":141710353,"eps":-2.224662,"marketStatus":"Not Yet Opened","change":0.05,"latestTime":"11-11 16:00:00 EST","open":9.5,"high":9.5,"low":9.0302,"amount":24335275.744677998,"amplitude":0.050789,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.224662,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794474000000},"marketStatusCode":0,"adr":0,"adrRate":1,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":9.25,"preHourTrading":{"tag":"盘前","latestPrice":9.41,"preClose":9.25,"latestTime":"09:28 EST","volume":32697,"amount":311008.534389,"timestamp":1794407322988,"change":0.16,"changeRate":0.017297,"amplitude":0.024865},"postHourTrading":{"tag":"盘后","latestPrice":9.2713,"preClose":9.3,"latestTime":"19:58 EST","volume":23449,"amount":218139.8912,"timestamp":1794445129671,"change":-0.0287,"changeRate":-0.003086,"amplitude":0.02043},"volumeRatio":0.636518,"impliedVol":0.8258,"impliedVolPercentile":0.388},"requestUrl":"/m/hq/s/CMPS/","defaultTab":"news","newsList":[{"id":"2682749556","title":"COMPASS Pathways (CMPS) Is Getting Fresh Attention, What Is The Market Weighing?","url":"https://stock-news.laohu8.com/highlight/detail?id=2682749556","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682749556?lang=en_us&edition=fundamental","pubTime":"2026-11-12 14:20","pubTimestamp":1794464446,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 12, 2026","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-is-getting-fresh-attention-what-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-is-getting-fresh-attention-what-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682306816","title":"Compass Pathways Participates in Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2682306816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682306816?lang=en_us&edition=fundamental","pubTime":"2026-11-11 19:30","pubTimestamp":1794396647,"startTime":"0","endTime":"0","summary":"Compass Pathways Participates in Jefferies Global Healthcare ConferenceCompass Pathways management will attend the Jefferies Global Healthcare Conference on Nov. 18-19, 2026.A fireside chat is schedul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nNDL2vyty2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682335988","title":"RBC Capital Reaffirms Their Buy Rating on COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2682335988","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682335988?lang=en_us&edition=fundamental","pubTime":"2026-11-10 09:48","pubTimestamp":1794275289,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on COMPASS Pathways yesterday and set a price target of $21.00. According to TipRanks, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-compass-pathways-cmps-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-compass-pathways-cmps-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682381941","title":"Compass Pathways Submits NDA for COMP360 Psilocybin to FDA for Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2682381941","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682381941?lang=en_us&edition=fundamental","pubTime":"2026-11-09 22:37","pubTimestamp":1794235041,"startTime":"0","endTime":"0","summary":"Compass Pathways  said Monday it has submitted a new drug application to the US Food and Drug Administration for COMP360 psilocybin,   investigational formulation for treatment-resistant depression.The submission is supported by data from two phase 3 trials and a phase 2b study, each of which met its primary endpoint, and involved a total more than 1,000 participants living with highly chronic treatment-resistant depression, the company said.Shares of Compass Pathways were 0.2% higher in early trading on Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CMPS","LABU","PSIL","BK4139","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2682802625","title":"Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), COMPASS Pathways (CMPS) and Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2682802625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682802625?lang=en_us&edition=fundamental","pubTime":"2026-11-09 19:40","pubTimestamp":1794224416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aclaris Therapeutics (ACRS), COMPASS Pathways (CMPS)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aclaris-therapeutics-acrs-compass-pathways-cmps-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aclaris-therapeutics-acrs-compass-pathways-cmps-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XBI","BK4137","BK4007","PSIL","BK4581","ACRS","LU0029874061.USD","LABU","XLV","CMPS","BK4585","BK4139","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682804741","title":"Compass Pathways Completes Comp360 Psilocybin New Drug Application to U.S. FDA for Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2682804741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682804741?lang=en_us&edition=fundamental","pubTime":"2026-11-09 19:30","pubTimestamp":1794223800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261109:nTUA5524CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682380286","title":"Compass Pathways - Expected Launch of Comp360 in H1 2027 Subject to FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2682380286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682380286?lang=en_us&edition=fundamental","pubTime":"2026-11-09 19:30","pubTimestamp":1794223800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261109:nTUA5524CQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682049628","title":"Compass Pathways Price Target Maintained with a $65.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2682049628","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682049628?lang=en_us&edition=fundamental","pubTime":"2026-11-09 19:19","pubTimestamp":1794223140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681649118","title":"COMPASS Pathways Stock In Focus As FDA Filing Nears Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2681649118","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681649118?lang=en_us&edition=fundamental","pubTime":"2026-11-06 21:34","pubTimestamp":1793972075,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 6, 2026","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-stock-in-focus-as-fda-filing-nears-completi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-stock-in-focus-as-fda-filing-nears-completi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JOYT","VGFPF","RGLO","VOTE","BK4139","PSIL","GXDW","LABU","FEBU","PMDE","CMPS","DECU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681886539","title":"Compass Pathways Grants Equity Awards to Nine New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2681886539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681886539?lang=en_us&edition=fundamental","pubTime":"2026-11-06 06:58","pubTimestamp":1793919502,"startTime":"0","endTime":"0","summary":"Compass Pathways Grants Equity Awards to Nine New EmployeesCompass Pathways granted nine newly hired non-executive employees equity awards on November 2, 2026, under its 2026 Inducement Plan.Options c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nNDL1cBr4l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681000348","title":"Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681000348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681000348?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:30","pubTimestamp":1793914200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nTUA9FKQ1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681810010","title":"COMPASS Pathways (CMPS) Nears COMP360 NDA Submission, Is It Still A Bargain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2681810010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681810010?lang=en_us&edition=fundamental","pubTime":"2026-11-05 13:35","pubTimestamp":1793856900,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 5, 2026","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-nears-comp360-nda-submission-is-it-sti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-nears-comp360-nda-submission-is-it-sti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681666760","title":"Compass Pathways Remains on Track for COMP360 Launch Following Q3 Results, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2681666760","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681666760?lang=en_us&edition=fundamental","pubTime":"2026-11-05 01:04","pubTimestamp":1793811844,"startTime":"0","endTime":"0","summary":"Compass Pathways  reported Q3 results, with near-term catalysts for its targeted H1 2027 COMP360 launch remaining on track, RBC Capital Markets said in a note Tuesday.The company expects to submit its new drug application for COMP360 in treatment-resistant depression, or TRD, in two weeks, while its post-traumatic stress disorder trial remains ongoing and could provide additional long-term growth opportunities, the analysts said.The analysts said they continue to see strong potential for the TRD program, supported by positive interest from doctors, insurers, and patients.They added that while the initial launch may take time to gain momentum, they see a $1.7 billion long-term market opportunity and view the recent stock pullback as a buying opportunity.RBC has an outperform, speculative risk rating and a $21 price target on Compass Pathways.Price: 8.43, Change: -0.16, Percent Change: -1.86","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680055796","title":"Nuvectis Pharma Q3 Net Loss Widens on Licensing and R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2680055796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680055796?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:12","pubTimestamp":1793794325,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Q3 net loss widens on licensing and R&D costsOverviewUS biopharma firm's Q3 net loss widened, driven by upfront licensing payments and higher R&D spendCompany ended Q3 with $140.7 mln ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L0MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1861558580.USD","BK4588","CMPS","BEAM","BK4139","PSIL","BK4535","BK4556","LU1861559042.SGD","BK4505","BK4611","NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680177892","title":"Compass Pathways Price Target Maintained with a $25.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2680177892","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680177892?lang=en_us&edition=fundamental","pubTime":"2026-11-03 23:29","pubTimestamp":1793719740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680727129","title":"Compass Pathways PLC Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2680727129","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680727129?lang=en_us&edition=fundamental","pubTime":"2026-11-03 22:32","pubTimestamp":1793716350,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC reports results for the quarter ended September 30 - Earnings SummaryCompass Pathways PLCCMPS.OQreported a quarterly adjusted loss of 7 cents per share for the quarter ended Septe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nL5N46K1RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680252187","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2680252187","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680252187?lang=en_us&edition=fundamental","pubTime":"2026-11-03 20:11","pubTimestamp":1793707909,"startTime":"0","endTime":"0","summary":"Rising Dragon Acquisition  shares were 138% higher in premarket activity on Tuesday after the company announced a mutual termination of its merger agreement with HZJL Cayman.Mercer International  shares were up 83% following the announcement of a recapitalization agreement that is expected to reduce the company's existing senior note debt.Backblaze  stock was up 33% following the company's Q3 financial results.Harmonic  stock was 17% higher after the company reported higher fiscal Q3 adjusted earnings and revenue.COMPASS Pathways  shares are up 9% after the company posted Q3 financial results.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HLIT","BK4020","BK4116","BK4199","MERC","BLZE","CMPS","BK4139","PSIL","RDAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680728730","title":"Earnings Flash (CMPS) Compass Pathways Posts Q3 Loss $0.31 a Share, vs. FactSet Est of $0.39 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2680728730","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680728730?lang=en_us&edition=fundamental","pubTime":"2026-11-03 19:46","pubTimestamp":1793706418,"startTime":"0","endTime":"0","summary":"Earnings Flash (CMPS) Compass Pathways Posts Q3 Loss $0.31 a Share, vs. FactSet Est of $0.39 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680272863","title":"Compass Pathways Q3 EPS $(0.31) Beats $(0.43) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2680272863","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680272863?lang=en_us&edition=fundamental","pubTime":"2026-11-03 19:32","pubTimestamp":1793705557,"startTime":"0","endTime":"0","summary":"Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.43) by 27.91 percent. This is a 18.42 percent increase over losses of $(0.38) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62811312/compass-pathways-q3-eps-0-31-beats-0-43-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680372889","title":"Compass Pathways Q3 Net Loss Narrows 93% to USD 9.83 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680372889","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680372889?lang=en_us&edition=fundamental","pubTime":"2026-11-03 19:32","pubTimestamp":1793705549,"startTime":"0","endTime":"0","summary":"Compass Pathways Q3 net loss narrows 93% to USD 9.83 millionCompass Pathways’ third-quarter 2026 net loss narrowed 93% year over year to $9.83 million, primarily due to noncash warrant fair-value adju","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL55Ybqh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.compasspathways.com","stockEarnings":[{"period":"1week","weight":0.0814},{"period":"1month","weight":-0.1934},{"period":"3month","weight":-0.3002},{"period":"6month","weight":-0.1032},{"period":"1year","weight":0.6316},{"period":"ytd","weight":0.3478}],"compareEarnings":[{"period":"1week","weight":-0.0091},{"period":"1month","weight":-0.0235},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.0279},{"period":"1year","weight":0.1125},{"period":"ytd","weight":0.1142}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053854},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.067409},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.124725},{"month":4,"riseRate":0.5,"avgChangeRate":0.092687},{"month":5,"riseRate":0.5,"avgChangeRate":0.037097},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.001204},{"month":7,"riseRate":0.666667,"avgChangeRate":0.185901},{"month":8,"riseRate":0.5,"avgChangeRate":0.026891},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.097517},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.017872},{"month":11,"riseRate":0.285714,"avgChangeRate":0.001771},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01163}],"exchange":"NASDAQ","name":"COMPASS Pathways plc","nameEN":"COMPASS Pathways plc","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"COMPASS Pathways plc,CMPS,COMPASS Pathways plc股票,COMPASS Pathways plc股票老虎,COMPASS Pathways plc股票老虎国际,COMPASS Pathways plc行情,COMPASS Pathways plc股票行情,COMPASS Pathways plc股价,COMPASS Pathways plc股市,COMPASS Pathways plc股票价格,COMPASS Pathways plc股票交易,COMPASS Pathways plc股票购买,COMPASS Pathways plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}